Adopting Site Quality Management to Optimize Risk-Based Monitoring
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
As it is now well documented, clinical R&D organizations have been actively embarking on a paradigm shift in their approach to ensuring quality in the conduct of clinical trials. In particular, a more targeted, risk-based approach to site monitoring and data cleaning is being actively pursued by organizations both large and small. The primary goals of this new paradigm include significant improvements in resource efficiency associated with clinical R&D, increased quality in trial conduct and corresponding data, and the maintenance or even reduction of clinical trial timelines.
While the interest in this paradigm has increased steadily in recent years, progress had been significantly impeded by a variety of factors. However, now that electronic data capture (EDC) technology is near ubiquitous and the FDA has delivered guidance in favor of centralized monitoring, sponsors are now more interested than ever in trying to implement a risk-based monitoring strategy.
This white paper will help you understand the challenges faced when implementing risk-based monitoring and how developing a site quality management program, especially one leveraging real-time site quality analytics, can simplify the adoption and increase your chances for success.
Have Your Say
Rate this feature and give us your feedback in the comments section below
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.